Literature DB >> 20160199

Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts.

Giulio Agnetti1, Nina Kaludercic, Lesley A Kane, Steven T Elliott, Yurong Guo, Khalid Chakir, Daya Samantapudi, Nazareno Paolocci, Gordon F Tomaselli, David A Kass, Jennifer E Van Eyk.   

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) improves chamber mechanoenergetics and morbidity and mortality of patients manifesting heart failure with ventricular dyssynchrony; however, little is known about the molecular changes underlying CRT benefits. We hypothesized that mitochondria may play an important role because of their involvement in energy production. METHODS AND
RESULTS: Mitochondria isolated from the left ventricle in a canine model of dyssynchronous or resynchronized (CRT) heart failure were analyzed by a classical, gel-based, proteomic approach. Two-dimensional gel electrophoresis revealed that 31 mitochondrial proteins where changed when controlling the false discovery rate at 30%. Key enzymes in anaplerotic pathways, such as pyruvate carboxylation and branched-chain amino acid oxidation, were increased. These concerted changes, along with others, suggested that CRT may increase the pool of Krebs cycle intermediates and fuel oxidative phosphorylation. Nearly 50% of observed changes pertained to subunits of the respiratory chain. ATP synthase-beta subunit of complex V was less degraded, and its phosphorylation modulated by CRT was associated with increased formation (2-fold, P=0.004) and specific activity (+20%, P=0.05) of the mature complex. The importance of these modifications was supported by coordinated changes in mitochondrial chaperones and proteases. CRT increased the mitochondrial respiratory control index with tightened coupling when isolated mitochondria were reexposed to substrates for both complex I (glutamate and malate) and complex II (succinate), an effect likely related to ATP synthase subunit modifications and complex quantity and activity.
CONCLUSIONS: CRT potently affects both the mitochondrial proteome and the performance associated with improved cardiac function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20160199      PMCID: PMC2921909          DOI: 10.1161/CIRCGENETICS.109.871236

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  33 in total

Review 1.  Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle.

Authors:  M J Gibala; M E Young; H Taegtmeyer
Journal:  Acta Physiol Scand       Date:  2000-04

Review 2.  Reverse engineering a protein: the mechanochemistry of ATP synthase.

Authors:  G Oster; H Wang
Journal:  Biochim Biophys Acta       Date:  2000-05-31

3.  Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae.

Authors:  Scott B Ficarro; Mark L McCleland; P Todd Stukenberg; Daniel J Burke; Mark M Ross; Jeffrey Shabanowitz; Donald F Hunt; Forest M White
Journal:  Nat Biotechnol       Date:  2002-03       Impact factor: 54.908

Review 4.  Membrane protein degradation by AAA proteases in mitochondria.

Authors:  Isabel Arnold; Thomas Langer
Journal:  Biochim Biophys Acta       Date:  2002-09-02

5.  Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.

Authors:  Blagoy Blagoev; Shao-En Ong; Irina Kratchmarova; Matthias Mann
Journal:  Nat Biotechnol       Date:  2004-08-15       Impact factor: 54.908

6.  The different effects of leucine, isoleucine, and valine on systolic properties of the normal and septic isolated rat heart.

Authors:  L J Markovitz; Y Hasin; E J Dann; M S Gotsman; H R Freund
Journal:  J Surg Res       Date:  1985-03       Impact factor: 2.192

7.  Control of energy production in the heart: a new function for fatty acid binding protein.

Authors:  N C Fournier; M Rahim
Journal:  Biochemistry       Date:  1985-04-23       Impact factor: 3.162

8.  Regional alterations in protein expression in the dyssynchronous failing heart.

Authors:  David D Spragg; Christophe Leclercq; Morteza Loghmani; Owen P Faris; Richard S Tunin; Deborah DiSilvestre; Elliot R McVeigh; Gordon F Tomaselli; David A Kass
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

9.  Utilization of leucine by working rat heart.

Authors:  K Ichihara; J R Neely; D L Siehl; H E Morgan
Journal:  Am J Physiol       Date:  1980-12

10.  Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level.

Authors:  Andreas S Barth; Takeshi Aiba; Victoria Halperin; Deborah DiSilvestre; Khalid Chakir; Carlo Colantuoni; Richard S Tunin; Victoria Lea Dimaano; Wayne Yu; Theodore P Abraham; David A Kass; Gordon F Tomaselli
Journal:  Circ Cardiovasc Genet       Date:  2009-05-15
View more
  55 in total

Review 1.  Cellular electrophysiological abnormalities in dyssynchronous hearts and during CRT.

Authors:  Marc Vanderheyden; Martin Penicka; Jozef Bartunek
Journal:  J Cardiovasc Transl Res       Date:  2011-12-07       Impact factor: 4.132

2.  Rethinking Resynch: Exploring Mechanisms of Cardiac Resynchroniztion Beyond Wall Motion Control.

Authors:  Khalid Chakir; David A Kass
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 3.  Transcriptome, proteome, and metabolome in dyssynchronous heart failure and CRT.

Authors:  Andreas S Barth; Khalid Chakir; David A Kass; Gordon F Tomaselli
Journal:  J Cardiovasc Transl Res       Date:  2012-02-07       Impact factor: 4.132

4.  Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy.

Authors:  Sarah Franklin; Michael J Zhang; Haodong Chen; Anna K Paulsson; Scherise A Mitchell-Jordan; Yifeng Li; Peipei Ping; Thomas M Vondriska
Journal:  Mol Cell Proteomics       Date:  2010-08-31       Impact factor: 5.911

Review 5.  The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy.

Authors:  Marc Vanderheyden; Chris Vrints; Jozef Bartunek
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

Review 6.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

7.  Right ventricular protein expression profile in end-stage heart failure.

Authors:  Yan Ru Su; Manuel Chiusa; Evan Brittain; Anna R Hemnes; Tarek S Absi; Chee Chew Lim; Thomas G Di Salvo
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

Review 8.  Epidemiology of "Heart Failure with Recovered Ejection Fraction": What do we do After Recovery?

Authors:  Johny S Kuttab; Michael S Kiernan; Amanda R Vest
Journal:  Curr Heart Fail Rep       Date:  2015-12

Review 9.  Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system.

Authors:  Heaseung S Chung; Sheng-Bing Wang; Vidya Venkatraman; Christopher I Murray; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

10.  Cardiac resynchronization therapy induces adaptive metabolic transitions in the metabolomic profile of heart failure.

Authors:  Emirhan Nemutlu; Song Zhang; Yi-Zhou Xu; Andre Terzic; Li Zhong; Petras D Dzeja; Yong-Mei Cha
Journal:  J Card Fail       Date:  2015-04-22       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.